http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1062389-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C243-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C- |
| filingDate | 1966-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1967-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1062389-A |
| titleOfInvention | Novel hydrazine derivatives and a process for the manufacture thereof |
| abstract | Novel hydrazine derivatives of the general formula <FORM:1062389/C2/1> wherein X represents a lower-alkyl group and Y represents the cation of an inorganic or organic acid are obtained by reacting 1-(p-formyl-benzyl)-2-methyl-hydrazine or an acid addition salt thereof with a semicarbazide of the formula <FORM:1062389/C2/2> or an acid addition salt thereof in the presence of an acid agent and, if desired, converting the resulting acid addition salt by neutralization and reaction with a different acid into a different acid addition salt. Pharmaceutical compositions having cytostatic activity and containing the above compounds are administered as tablets, dragees, suppositories, capsules, solutions, suspensions or emulsions. |
| priorityDate | 1965-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.